Gracell Biotechnologies Inc. Quarterly Liabilities, Current in CNY from Q4 2019 to Q2 2023

Taxonomy & unit: us-gaap: CNY and USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Gracell Biotechnologies Inc. quarterly Liabilities, Current history and growth rate from Q4 2019 to Q2 2023.
Gracell Biotechnologies Inc. Liabilities, Current for the quarter ending June 30, 2023 was ¥194M, a 10.7% decline year-over-year.

Liabilities, Current, Quarterly (CNY)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	194M	-23.3M	-10.7%	Jun 30, 2023	6-K	2023-08-14
Q4 2022	221M	+65.5M	+42.2%	Dec 31, 2022	6-K	2023-08-14
Q2 2022	217M			Jun 30, 2022	6-K	2022-08-15
Q4 2021	155M	+61.8M	+66.2%	Dec 31, 2021	20-F	2023-04-25
Q4 2020	93.4M	+75.2M	+414%	Dec 31, 2020	20-F	2022-04-22
Q4 2019	18.2M			Dec 31, 2019	20-F	2021-04-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.